Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

SWX/SKAN stock hub

SWX/SKAN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SWX/SKANis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.1B

SIX Swiss Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SWX/SKAN

In the news

Latest news · SWX/SKAN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E35.1

P25 n/aP50 n/aP75 n/a

Trailing P/E65.8

P25 n/aP50 n/aP75 n/a

ROE10.6

P25 n/aP50 n/aP75 n/a

ROIC12.7

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SWX/SKAN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

236

Groups with data

Currency

CHF

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	CH
Employees	1,737
Employees Change	115%
Employees Change Percent	7.09
Enterprise value	CHF 1.1B
Exchange	SIX Swiss Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical Instruments & Supplies
Isin	CH0013396012
Last refreshed	2026-05-10
Market cap	CHF 1.1B
Price	CHF 47.6
Price currency	CHF
Rev Per Employee	202,389.19x
Sector	Healthcare
Sic	3845
Symbol	swx/SKAN
Website	https://skan.com/de/home/

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.52%
EV Earnings	68.87x
EV/EBIT	44.04x
EV/EBITDA	31.57x
EV/FCF	53.35x
EV/Sales	3.36x
FCF yield	1.96%
Forward P/E	35.12x
P/B ratio	8.39x
P/E ratio	65.76x
P/S ratio	3.21x
PE Ratio10 Y	88.28x
PE Ratio3 Y	66.31x
PE Ratio5 Y	65.31x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	7.63%
EBITDA Margin	10.64%
FCF margin	6.3%
Gross margin	74.91%
Gross Profit	CHF 249.7M
Gross Profit Growth	3.4%
Gross Profit Growth Q	6.12%
Gross Profit Growth3 Y	0.19%
Gross Profit Growth5 Y	2.88%
Net Income	CHF 16.3M
Net Income Growth	-58.06%
Net Income Growth Q	0.39%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-20.38%
Net Income Growth5 Y	-9.85%
Pretax Margin	6.41%
Profit Margin	4.88%
Profit Per Employee	CHF 9,881
Profitable Years	14
ROA	3.67
Roa5y	5.44
ROCE	9.38
ROE	10.64
Roe5y	15.56
ROIC	12.66
Roic5y	36.89

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	26.78%
Cagr15y	20.22%
Cagr1y	-31.22%
Cagr3y	-17.29%
Cagr5y	8.44%
Div CAGR10	0.96%
Div CAGR3	-4.17%
Div CAGR5	-36.73%
EPS Growth	-58.06
EPS Growth Q	0.39
EPS Growth Years	0
EPS Growth3 Y	-20.38
EPS Growth5 Y	-9.85
FCF Growth Q	16.78%
FCF Growth5 Y	18.99%
OCF Growth	37.28%
OCF Growth Q	-9.72%
OCF Growth10 Y	10.97%
OCF Growth3 Y	64.66%
OCF Growth5 Y	16.68%
Revenue Growth	-7.74x
Revenue Growth Q	0.61x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	-1.05x
Revenue Growth5 Y	2.42x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.77
Assets	CHF 481.1M
Cash	CHF 94.1M
Current Assets	CHF 275.6M
Current Liabilities	CHF 210M
Debt	CHF 131.5M
Debt EBITDA	CHF 3.71
Debt Equity	CHF 1.03
Debt FCF	CHF 6.26
Equity	CHF 127.6M
Interest Coverage	25.97
Liabilities	CHF 353.5M
Long Term Assets	CHF 205.4M
Long Term Liabilities	CHF 143.5M
Net Cash	CHF -37.4M
Net Cash By Market Cap	CHF -3.49
Net Debt EBITDA	CHF 1.05
Net Debt Equity	CHF 0.29
Net Debt FCF	CHF 1.78
Tangible Book Value	CHF 101.5M
Tangible Book Value Per Share	CHF 4.51
WACC	7.34

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.31
Inventory Turnover	0.72
Net Working Capital	CHF -26.6M
Quick ratio	0.69
Working Capital	CHF 65.6M
Working Capital Turnover	CHF 5.27

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	-45%
Dividend Growth Years	3%
Dividend per share	CHF 0.22
Dividend Years	7
Dividend Yield	0.46%
Ex Div Date	2026-05-11
Last Dividend	CHF 0.22
Payout Frequency	Annual
Payout Ratio	55.26%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	972.66%
1Y total return	-31.21%
200-day SMA	54.1
3Y total return	-43.43%
50-day SMA	46.64
50-day SMA vs 200-day SMA	50under200
5Y total return	49.96%
All Time High	95.19
All Time High Change	-49.99%
All Time High Date	2021-11-17
All Time Low	3
All Time Low Change	1,484.55%
All Time Low Date	2010-12-31
ATR	1.93
Beta	0.71
Beta1y	1.02
Beta2y	0.91
Ch YTD	-9.85
High	48
High52	77.8
High52 Date	2025-07-28
High52ch	-38.82%
Low	46
Low52	35.75
Low52 Date	2026-03-24
Low52ch	33.15%
Ma50ch	2.05%
Price vs 200-day SMA	-12.01%
RSI	54.49
RSI Monthly	37.78
RSI Weekly	43.12
Sharpe ratio	-1.06x
Sortino ratio	-1.27
Total Return	0.46%
Tr YTD	-9.85
Tr15y	1,484.38%
Tr1m	17.82%
Tr1w	3.14%
Tr3m	-14.54%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 25.4M
Operating Income Growth	4.28
Operating Income Growth Q	3.56
Operating Income Growth3 Y	-14.4
Operating Income Growth5 Y	-6.71
Operating margin	7.63

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	12,708,796%
Net Borrowing	118,684,000
Shares Insiders	43.48%
Shares Institutions	22.22%
Shares Out	22,483,524
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF 21M
Average Volume	27,712.6x
Bv Per Share	5.09
CAPEX	CHF -43.1M
Ch10y	642.6
Ch15y	693.3
Ch1m	17.82
Ch1w	3.14
Ch1y	-31.61
Ch3m	-14.54
Ch3y	-44
Ch5y	38.78
Ch6m	-0.52
Change	-1.24%
Change From Open	3.48
Close	48.2
Days Gap	-4.56
Depreciation Amortization	10,049,000
Dollar Volume	1,120,408.8
Earnings Date	2026-08-18
EBIT	CHF 25.4M
EBITDA	CHF 35.5M
EPS	CHF 0.72
F Score	6
FCF	CHF 21M
FCF EV Yield	1.87x
FCF Per Share	CHF 0.93
Financing CF	108,987,000
Fiscal Year End	December
Founded	1,968
Graham Number	9.61356
Graham Upside	-79.8
Income Tax	CHF 3.8M
Investing CF	-130,906,000
Is Primary Listing	1
Last Earnings Date	2026-03-24
Last Report Date	2025-12-31
Lynch Fair Value	CHF 3.62
Lynch Upside	-92.4
Ma150	50.76
Ma150ch	-6.23%
Ma20	47.01
Ma20ch	1.25%
Net CF	40,370,000
Next Earnings Date	2026-08-18
Open	46
P FCF Ratio	50.95
P OCF Ratio	16.69
Payment Date	2026-05-13
Position In Range	80
Ppne	176,010,000
Price Date	2026-05-08
Price EBITDA	CHF 30.17
Ptbv Ratio	10.55
Relative Volume	0.87x
Revenue	333,335,000x
Tax By Revenue	1.14x
Tax Rate	17.83%
Tr6m	-0.52%
Volume	23,538
Z Score	3.54

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SWX/SKAN dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.5%

$0.22 annual per share

Payout ratio

+55.3%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-36.7%

3 consecutive years of growth

Total shareholder yield

+0.5%

Next ex-dividend date: 2026-05-11

Performance

SWX/SKAN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SWX/SKAN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+22.2%

Share of float held by funds and institutions

Insider ownership

+43.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

SWX/SKAN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.5

Neutral momentum band

Price vs 200-day MA

-12.0%

50/200-day relationship not available

Beta (5Y)

0.71

Less volatile than the market

Sharpe ratio

-1.06

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SWX/SKAN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current swx/SKAN stock rating?

swx/SKAN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full swx/SKAN analysis?

The full report lives at /stocks/swx/SKAN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for swx/SKAN?

The latest report frames swx/SKAN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the swx/SKAN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.